|
|
|
Volumn 26, Issue 1 SUPPL. 3, 1999, Pages 26-29
|
|
Recently initiated studies: Neoadjuvant treatments in the next century
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
CARMUSTINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EPIRUBICIN;
FLUOROURACIL;
GRANULOCYTE COLONY STIMULATING FACTOR;
MITOXANTRONE;
MONOCLONAL ANTIBODY;
NAVELBINE;
PACLITAXEL;
PROTEIN KINASE INHIBITOR;
RETINOID;
TAMOXIFEN;
TAXANE DERIVATIVE;
THIOTEPA;
ARTICLE;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER HORMONE THERAPY;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CLINICAL TRIAL;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
STEM CELL TRANSPLANTATION;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CELL SURVIVAL;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
FEMALE;
HUMANS;
PACLITAXEL;
TAXOIDS;
|
|
EID: 0032994764
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (27)
|
